PATENTS RELATED TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS),

Although Dr. Demchick also represents patent seekers with non-microbiological inventions, his doctorate is in microbiology. Microbiology has been the primary focus of his research and teaching. He especially loves dealing with patent searches and applications for involving microbiology.

Dr. Demchick is a scientist with a quarter of a century of research experience in academic, industrial and governmental settings.

If you are considering patent protection for an invention, Dr. Demchick will be glad to discuss the matter with you. There is no charge for an initial discussion.

The following sampling is to give you some sense of the types of Human immunodeficiency virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS), related inventions which have received United States patent protection. The patent list is not exhaustive and is certainly not a substitute for a proper patent search . It should be noted that only U.S. Patents are included.

It should be noted that spelling, form and typographical errors in the original patents are preserved here.

Herbal composition and method of treating HIV infection (United States Patent 7,160,561)

Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as AIDS (United States Patent 7,144,922)

Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy (United States Patent 7,144,577)

Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids (United States Patent 7,122,190)

Chimeric protein for prevention and treatment of HIV infection (United States Patent 7,115,262)

CCR5 antagonists useful for treating AIDS (United States Patent 7,098,213)

Combined therapy for treatment of HIV infection (United States Patent 7,094,413)

CCR5 antagonists useful for treating AIDS (United States Patent 7,060,701)

Method of treating HIV infection and related secondary infections thereof (United States Patent 7,049,430)

CCR5 antagonists useful for treating AIDS (United States Patent 7,008,946)

Method of treatment of viral infection including HIV using water soluble fullerenes--III (United States Patent 6,979,566)

Pharmaceutical being used for treating HIV infection, the composition and uses thereof (United States Patent 6,962,900)

Methods of treating HIV infected subjects (United States Patent 6,905,680)

CCR5 antagonists useful for treating aids (United States Patent 6,900,211)

.beta.-L-2'-deoxy-nucleosides for the treatment of HIV infection (United States Patent 6,896,900)

Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy (United States Patent 6,893,813)

HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides (United States Patent 6,869,933)

Treatment of AIDS with antibodies to gamma interferon, alpha interferon and TNF-alpha (United States Patent 6,863,890)

Methods and compositions for treatment of HIV-1 infection using antiviral compounds in simultaneous or sequential combinations (United States Patent 6,861,059)

AIDS DNA vaccine that prevents SIVmac239 virus infection in monkeys (United States Patent 6,818,442)

Methods of using cytokine antagonists to treat HIV infection and AIDS (United States Patent 6,811,780)

Treatment of HIV infections (United States Patent 6,800,616)

Methods for treating HIV-infected patients by the administration of GM-CSF and a protease inhibitor (United States Patent 6,800,280)

Methods of preventing and treating HIV infection (United States Patent 6,787,527)

Activated iododerivatives for the treatment of cancer and aids (United States Patent 6,780,995)

Phenoxyethyl-thiourea-pyridine compounds and their use for treatment of HIV-infections (United States Patent 6,727,265)

Methods for preventing HIV-1 or HIV-2 infection (United States Patent 6,727,240)

CCR5 antagonists useful for treating aids (United States Patent 6,720,325)

Peptides for treatment of HIV infection (United States Patent 6,713,445)

Immune enhancing agent for treating HIV infected humans (United States Patent 6,713,064)

Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of HIV to uninfected cells and contraceptive compositions comprising the said derivatives (United States Patent 6,710,077)

Phenylindoles for the treatment of HIV (United States Patent 6,710,068)

Method of treating HIV infection and related secondary infections thereof (United States Patent 6,699,985)

Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin (United States Patent 6,699,656)

Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy (United States Patent 6,696,063)

Methods for treating dementia due to HIV disease (United States Patent 6,689,795)

Composition and methods for treatment of HIV infection (United States Patent 6,689,762)

3-(amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases (United States Patent 6,683,079)

Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease (United States Patent 6,667,151)

Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor (United States Patent 6,649,644)

Method for treating HIV (United States Patent 6,620,416)

Method of treatment of viral infection including HIV using water soluble fullerenes (United States Patent 6,613,771)

Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor (United States Patent 6,576,231)

DNA encoding the T cell surface protein CD4 and use of fragments of CD4 in the treatment of AIDS (United States Patent 6,570,000)

Compositions and methods for preventing transepithelial transmission of HIV (United States Patent 6,566,095)

Treatment of AIDS-associated non-Hodgkin's lymphoma by gallium nitrate (United States Patent 6,562,870)

Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV (United States Patent 6,544,961)

Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy (United States Patent 6,514,758)

Activated iododerivatives for the treatment of cancer and aids (United States Patent 6,511,988)

Treatment of HIV (United States Patent 6,503,882)

Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy (United States Patent 6,498,006)

Method for the control and treatment of acquired immunodeficiency syndrome (AIDS) (United States Patent 6,492,352)

Methods for treating hemophilia A and B and AIDS and devices used therein (United States Patent 6,491,655)

Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV (United States Patent 6,486,136)

Botanical combinations for treating AIDS and immune-deficient patients to maintain good health and the process for preparing the same (United States Patent 6,485,759)

Method for control and treatment of acquired immunodeficiency syndrome (AIDS) (United States Patent 6,476,009)

Treatment of HIV and other viral infections using combinatorial therapy (United States Patent 6,475,491)

Topical immunomodulating compositions for treatment of aids, Hepatitis B & C, other infectious diseases, and cancer (United States Patent 6,455,586)

Anti-HIV infection agents and method for treating HIV infection (United States Patent 6,455,555)

Medicinal herbal composition for treating liver diseases and HIV (United States Patent 6,455,078)

3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases (United States Patent 6,451,822)

Peptide compositions for the treatment of HIV infection (United States Patent 6,447,778)

Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids (United States Patent 6,420,141)

.beta.-L nucleosides for the treatment of HIV infection (United States Patent 6,407,077)

Method and compositions for preventing or reducing HIV infection (United States Patent 6,406,701)

Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection (United States Patent 6,369,235)

Method of treating complications in immunodepressed states resulting from HIV infection (United States Patent 6,368,788)

Hematopoietic cell method for treatment of HIV infection (United States Patent 6,365,404)

Method of treating HIV infection with transdermal gel containing mammalian liver extract (United States Patent 6,350,472)

Method for preventing HIV-1 infection of CD4+ cells (United States Patent 6,344,545)

Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin (United States Patent 6,331,610)

Composition and method for prevention of sexually transmitted diseases, including aids (United States Patent 6,328,991)

Anti-viral guanosine-rich oligonucleotides and method of treating HIV (United States Patent 6,323,185)

Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection (United States Patent 6,319,666)

Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin (United States Patent 6,319,504)

Methods for treating HIV-infected patients by administering GM-CSF (United States Patent 6,309,632)

Activated iododerivatives for the treatment of cancer and AIDS (United States Patent 6,306,871)

Compositions and methods useful in treatment and prevention of HIV-1 infection (United States Patent 6,287,605)

Method for treating HIV with chlorine dioxide and a phosphate compound (United States Patent 6,274,132)

Hematopoietic cell method for treatment of HIV infection (United States Patent 6,271,028)

Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection (United States Patent 6,270,957)

HIV and viral treatment (United States Patent 6,245,789)

Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases (United States Patent 6,242,461)

Treatment of HIV by administration of .beta.-D-2', 3'-didehydro-2',3'-dideoxy-5-fluorocytidine (D4FC) (United States Patent 6,232,300)

Activated iododerivatives for the treatment of cancer and AIDS (United States Patent 6,225,323)

Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors (United States Patent 6,221,400)

Method for treating diseased states, in particular AIDS, using an electromagnetic generator (United States Patent 6,217,604)

Process of determining the efficacy of drug treatment in HIV infected subjects (United States Patent 6,210,875)

Method for the treatment of HIV infected cells (United States Patent 6,210,653)

Method of treating HIV by a topical composition (United States Patent 6,200,557)

3'-azido-2',3'-dideoxyuridine administration to treat HIV and related test protocol (United States Patent 6,194,391)

Methanol derivatives for treatment of retroviral infections especially HIV infections (United States Patent 6,191,124)

Combination therapy for the treatment of AIDS (United States Patent 6,180,634)

Method for treating hemophilia A and B and AIDS and devices used therein (United States Patent 6,174,299)

Method of treating HIV infection with suppository containing mammalian liver extract (United States Patent 6,156,349)

Peptide compositions for the treatment of HIV (United States Patent 6,139,843)

Method of measuring and preventing unstable feedback in hearing aids (United States Patent 6,134,329)

Oral drugs for treating AIDS patients (United States Patent 6,120,772)

Therapeutic treatment for HIV infection (United States Patent 6,107,327)

Method for preventing HIV-1 infection of CD4.sup.+ cells (United States Patent 6,107,019)

Herbal composition and method of treating HIV infection (United States Patent 7,160,561)

Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as AIDS (United States Patent 7,144,922)

Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy (United States Patent 7,144,577)

Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids (United States Patent 7,122,190)

Chimeric protein for prevention and treatment of HIV infection (United States Patent 7,115,262)

CCR5 antagonists useful for treating AIDS (United States Patent 7,098,213)

Combined therapy for treatment of HIV infection (United States Patent 7,094,413)

CCR5 antagonists useful for treating AIDS (United States Patent 7,060,701)

Method of treating HIV infection and related secondary infections thereof (United States Patent 7,049,430)

CCR5 antagonists useful for treating AIDS (United States Patent 7,008,946)

Method of treatment of viral infection including HIV using water soluble fullerenes--III (United States Patent 6,979,566)

Pharmaceutical being used for treating HIV infection, the composition and uses thereof (United States Patent 6,962,900)

Methods of treating HIV infected subjects (United States Patent 6,905,680)

CCR5 antagonists useful for treating aids (United States Patent 6,900,211)

.beta.-L-2'-deoxy-nucleosides for the treatment of HIV infection (United States Patent 6,896,900)

Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy (United States Patent 6,893,813)

HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides (United States Patent 6,869,933)

Treatment of AIDS with antibodies to gamma interferon, alpha interferon and TNF-alpha (United States Patent 6,863,890)

Methods and compositions for treatment of HIV-1 infection using antiviral compounds in simultaneous or sequential combinations (United States Patent 6,861,059)

AIDS DNA vaccine that prevents SIVmac239 virus infection in monkeys (United States Patent 6,818,442)

Methods of using cytokine antagonists to treat HIV infection and AIDS (United States Patent 6,811,780)

Treatment of HIV infections (United States Patent 6,800,616)

Methods for treating HIV-infected patients by the administration of GM-CSF and a protease inhibitor (United States Patent 6,800,280)

Methods of preventing and treating HIV infection (United States Patent 6,787,527)

Activated iododerivatives for the treatment of cancer and aids (United States Patent 6,780,995)

Phenoxyethyl-thiourea-pyridine compounds and their use for treatment of HIV-infections (United States Patent 6,727,265)

Methods for preventing HIV-1 or HIV-2 infection (United States Patent 6,727,240)

CCR5 antagonists useful for treating aids (United States Patent 6,720,325)

Peptides for treatment of HIV infection (United States Patent 6,713,445)

Immune enhancing agent for treating HIV infected humans (United States Patent 6,713,064)

Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of HIV to uninfected cells and contraceptive compositions comprising the said derivatives (United States Patent 6,710,077)

Phenylindoles for the treatment of HIV (United States Patent 6,710,068)

Method of treating HIV infection and related secondary infections thereof (United States Patent 6,699,985)

Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin (United States Patent 6,699,656)

Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy (United States Patent 6,696,063)

Methods for treating dementia due to HIV disease (United States Patent 6,689,795)

Composition and methods for treatment of HIV infection (United States Patent 6,689,762)

3-(amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases (United States Patent 6,683,079)

Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease (United States Patent 6,667,151)

Method of treating HIV infection by combined use of a cytotoxic agent and a non-nucleoside reverse transcriptase inhibitor (United States Patent 6,649,644)

Method for treating HIV (United States Patent 6,620,416)

Method of treatment of viral infection including HIV using water soluble fullerenes (United States Patent 6,613,771)

Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor (United States Patent 6,576,231)

DNA encoding the T cell surface protein CD4 and use of fragments of CD4 in the treatment of AIDS (United States Patent 6,570,000)

Compositions and methods for preventing transepithelial transmission of HIV (United States Patent 6,566,095)

Treatment of AIDS-associated non-Hodgkin's lymphoma by gallium nitrate (United States Patent 6,562,870)

Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV (United States Patent 6,544,961)

Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy (United States Patent 6,514,758)

Activated iododerivatives for the treatment of cancer and aids (United States Patent 6,511,988)

Treatment of HIV (United States Patent 6,503,882)

Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy (United States Patent 6,498,006)

Method for the control and treatment of acquired immunodeficiency syndrome (AIDS) (United States Patent 6,492,352)

Methods for treating hemophilia A and B and AIDS and devices used therein (United States Patent 6,491,655)

Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV (United States Patent 6,486,136)

Botanical combinations for treating AIDS and immune-deficient patients to maintain good health and the process for preparing the same (United States Patent 6,485,759)

Method for control and treatment of acquired immunodeficiency syndrome (AIDS) (United States Patent 6,476,009)

Treatment of HIV and other viral infections using combinatorial therapy (United States Patent 6,475,491)

Topical immunomodulating compositions for treatment of aids, Hepatitis B & C, other infectious diseases, and cancer (United States Patent 6,455,586)

Anti-HIV infection agents and method for treating HIV infection (United States Patent 6,455,555)

Medicinal herbal composition for treating liver diseases and HIV (United States Patent 6,455,078)

3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases (United States Patent 6,451,822)

Peptide compositions for the treatment of HIV infection (United States Patent 6,447,778)

Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids (United States Patent 6,420,141)

.beta.-L nucleosides for the treatment of HIV infection (United States Patent 6,407,077)

Method and compositions for preventing or reducing HIV infection (United States Patent 6,406,701)

Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection (United States Patent 6,369,235)

Method of treating complications in immunodepressed states resulting from HIV infection (United States Patent 6,368,788)

Hematopoietic cell method for treatment of HIV infection (United States Patent 6,365,404)

Method of treating HIV infection with transdermal gel containing mammalian liver extract (United States Patent 6,350,472)

Method for preventing HIV-1 infection of CD4+ cells (United States Patent 6,344,545)

Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin (United States Patent 6,331,610)

Composition and method for prevention of sexually transmitted diseases, including aids (United States Patent 6,328,991)

Anti-viral guanosine-rich oligonucleotides and method of treating HIV (United States Patent 6,323,185)

Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection (United States Patent 6,319,666)

Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin (United States Patent 6,319,504)

Methods for treating HIV-infected patients by administering GM-CSF (United States Patent 6,309,632)

Activated iododerivatives for the treatment of cancer and AIDS (United States Patent 6,306,871)

Compositions and methods useful in treatment and prevention of HIV-1 infection (United States Patent 6,287,605)

Method for treating HIV with chlorine dioxide and a phosphate compound (United States Patent 6,274,132)

Hematopoietic cell method for treatment of HIV infection (United States Patent 6,271,028)

Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection (United States Patent 6,270,957)

HIV and viral treatment (United States Patent 6,245,789)

Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases (United States Patent 6,242,461)

Treatment of HIV by administration of .beta.-D-2', 3'-didehydro-2',3'-dideoxy-5-fluorocytidine (D4FC) (United States Patent 6,232,300)

Activated iododerivatives for the treatment of cancer and AIDS (United States Patent 6,225,323)

Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors (United States Patent 6,221,400)

Method for treating diseased states, in particular AIDS, using an electromagnetic generator (United States Patent 6,217,604)

Process of determining the efficacy of drug treatment in HIV infected subjects (United States Patent 6,210,875)

Method for the treatment of HIV infected cells (United States Patent 6,210,653)

Method of treating HIV by a topical composition (United States Patent 6,200,557)

3'-azido-2',3'-dideoxyuridine administration to treat HIV and related test protocol (United States Patent 6,194,391)

Methanol derivatives for treatment of retroviral infections especially HIV infections (United States Patent 6,191,124)

Combination therapy for the treatment of AIDS (United States Patent 6,180,634)

Method for treating hemophilia A and B and AIDS and devices used therein (United States Patent 6,174,299)

Method of treating HIV infection with suppository containing mammalian liver extract (United States Patent 6,156,349)

Peptide compositions for the treatment of HIV (United States Patent 6,139,843)

Method of measuring and preventing unstable feedback in hearing aids (United States Patent 6,134,329)

Oral drugs for treating AIDS patients (United States Patent 6,120,772)

Therapeutic treatment for HIV infection (United States Patent 6,107,327)

Method for preventing HIV-1 infection of CD4.sup.+ cells (United States Patent 6,107,019)

Although his recognition as a registered patent agent permits him to represent others in all patent matters before the United States Patent and Trademark Office, Dr. Demchick limits his practice to patent matters involving inventions for which he is confident that his expertise will allow him to serve his client well. He will gladly discuss whether he is comfortable handling cases involving inventions in a particular field. He will err on the side of declining cases if he has uncertainty about his ability to do what is needed in the case. Dr. Demchick does not represent clients in court. However, he refers clients to a patent attorney who does represent others in court, if it appears likely that patent related representation in court is appropriate. Dr. Demchick prepares and files non-provisional (regular) patent applications and provisional patent applications. He prepares and files utility patent applications and design patent applications. He prepares and files U.S. patent applications and international patent applications under the Patent Cooperation Treaty (PCT). He prepares and files applications to enter the U.S. National Phase for inventions for which international patent applications (PCT) were already filed. One of the matters he discusses with each client or potential client is which type of application(s) best meets that client's needs. He usually does a patent search (patentability search) as part of the preparation of a patent application. He discusses the value of patent searching with each inventor before agreeing to prepare a patent application for that inventor.